Quadrature Capital’s Nutex Health NUTX Stock Holding History

Quadrature Capital’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,909	Closed	-$1.11M	–	1348
2025 Q2	$1.11M	Buy	+8,909	New	+$1.15M	0.02%	392

Other funds holding NUTX

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quadrature Capital's NUTX Position: Q3 2025 in Review

Quadrature Capital sold out of Nutex Health (NUTX) in Q3 2025, closing a stake of 8,909 shares — an estimated $1.11M sold.

Quadrature Capital first reported a position in NUTX in Q2 2025 and held it in 1 quarter. The position peaked at $1.11M in Q2 2025. 95 funds tracked by Wall St. Rank hold NUTX as of Q3 2025.

Quadrature Capital reported no remaining Nutex Health position as of Q3 2025 after selling out during the quarter.
Quadrature Capital sold 8,909 Nutex Health shares in Q3 2025, an estimated $1.11M.
Quadrature Capital first reported a position in Nutex Health in Q2 2025 and held it in 1 quarter.
Quadrature Capital's Nutex Health position peaked at $1.11M in Q2 2025.
95 funds tracked by Wall St. Rank held Nutex Health as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.